+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A new class of non-peptidic cholecystokinin-B/gastrin receptor antagonists based on dibenzobicyclo[2.2.2]octane



A new class of non-peptidic cholecystokinin-B/gastrin receptor antagonists based on dibenzobicyclo[2.2.2]octane



Journal of Medicinal Chemistry 37(22): 3671-3673




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 045079432

Download citation: RISBibTeXText

PMID: 7966125

DOI: 10.1021/jm00048a001


Related references

Improving the affinity and selectivity of a nonpeptide series of cholecystokinin-B/gastrin receptor antagonists based on the dibenzobicyclo[2.2.2]octane skeleton. Journal of Medicinal Chemistry 38(21): 4294-4302, 1995

Dibenzobicyclo(2.2.2.)octane angiotensin II receptor antagonists. Bioorganic and Medicinal Chemistry Letters 5(3): 241-246, 1995

Non-peptide cholecystokinin-B/gastrin receptor antagonists based on bicyclic, heteroaromatic skeletons. Journal of Medicinal Chemistry 39(9): 1806-1815, 1996

Antiproliferative gastrin/cholecystokinin receptor antagonists target the 78-kDa gastrin-binding protein. Proceedings of the National Academy of Sciences of the United States of America 91(16): 7593-7597, 1994

Inhibition of gastrin-stimulated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumide. European Journal of Cancer 28a(8-9): 1462-1467, 1992

Synthesis and evaluation of a fluorescent non-peptidic cholecystokinin-B/gastrin receptor specific antagonist for cancer cell imaging. Chembiochem 13(2): 282-292, 2012

Ligand-based molecular modeling study on a chemically diverse series of cholecystokinin-B/gastrin receptor antagonists: generation of predictive model. Journal of Chemical Information and Modeling 45(6): 1934-1942, 2005

COOH-terminal fragments of cholecystokinin. A new class of cholecystokinin receptor antagonists. Biochimica et Biophysica Acta 757(2): 250-258, 1983

Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor. Molecular Pharmacology 50(2): 436-441, 1996

Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists. Journal of Biological Chemistry 258(11): 6746-6749, 1983

N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging. Journal of Nuclear Medicine 55(10): 1719-1725, 2014

Structure activity relationships in cholecystokinin derived peptides design of peptidic cholecystokinin antagonists. Aubry, A , M Marraud And B Vitoux (Ed ) Colloque Inserm (Institut National De La Sante Et De La Recherche Medicale), Vol 174 Deuxieme Forum Peptides; (Inserm (National Institute Of Health And Medical Research) Colloquium), Vol 174 Second Forum on Peptides; Nancy, France, May 2-6, 1988 Xxxix+612p Les Editions Inserm: Paris, France; John Libbey And Co Ltd : London, England, Uk Illus Paper 491-494, 1989

Affinity of cholecystokinin receptor antagonists for the gastrin-binding protein. European Journal of Pharmacology 388(1): 9-15, Jan 24, 2000

New drugs against gastric acid secretion, gastrin-cholecystokinin B receptor antagonists. Japanese Journal of Pharmacology 61(SUPPL 1): 60P, 1993

Cholecystokinin, Gastrin, Cholecystokinin/Gastrin Receptors, and Bitter Taste Receptor, TAS2R14: Trophoblast Expression and Signaling. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2019, 2019